Evolving EMRSA-15 epidemic in Singapore hospitals

J Med Microbiol. 2007 Mar;56(Pt 3):376-379. doi: 10.1099/jmm.0.46950-0.

Abstract

The aim of this study was to determine the extent of EMRSA-15 spread in hospitals in Singapore. Molecular analysis of 197 non-duplicate meticillin-resistant Staphylococcus aureus (MRSA) isolates collected from five acute care public hospitals in Singapore in May 2005 revealed that 66 (33.5%) were EMRSA-15 while 121 (61.4%) belonged to the endemic multidrug-resistant ST239 clone. Median and mode vancomycin MIC for both major clones of health-care-associated MRSA were relatively high at 2.0 microg ml-1. Subsequent laboratory surveillance data collected from the first half of 2006 confirmed increasing numbers of the EMRSA-15 clone--ranging from 25.0 to 66.1% of all MRSA isolated in local hospitals--replacing the ST239 clone island-wide.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Cluster Analysis
  • Cross Infection / epidemiology
  • Cross Infection / microbiology*
  • DNA, Bacterial / genetics
  • Disease Outbreaks*
  • Electrophoresis, Gel, Pulsed-Field
  • Endemic Diseases
  • Genotype
  • Hospitals
  • Humans
  • Methicillin Resistance
  • Molecular Epidemiology
  • Repetitive Sequences, Nucleic Acid / genetics
  • Singapore / epidemiology
  • Staphylococcal Infections / epidemiology
  • Staphylococcal Infections / microbiology*
  • Staphylococcus aureus / classification*
  • Staphylococcus aureus / drug effects
  • Staphylococcus aureus / genetics*
  • Staphylococcus aureus / isolation & purification
  • Vancomycin / pharmacology

Substances

  • Anti-Bacterial Agents
  • DNA, Bacterial
  • Vancomycin